Surrogate End-points for Prostate Cancer Specific Survival: Superiority of the Interval to Biochemical Failure: An Analysis of RTOG 9202 and 9413
D.A. Hamstra, J. Dignam, A. Porter, G.E. Hanks, C. Lawton, M. Roach, H.M. SandlerVolume:
81
Année:
2011
Langue:
english
DOI:
10.1016/j.ijrobp.2011.06.210
Fichier:
PDF, 42 KB
english, 2011